FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

28770111000001100: EN-Lysine 500mg tablets (Ennogen Healthcare Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 04-Feb 2015. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
89560701000001116 EN-Lysine 500mg tablets (Ennogen Healthcare Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
89560801000001113 EN-Lysine 500mg tablets (Ennogen Healthcare Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
EN-Lysine 500mg tablets (Ennogen Healthcare Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
EN-Lysine 500mg tablets (Ennogen Healthcare Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
EN-Lysine 500mg tablets (Ennogen Healthcare Ltd) Is a L-lysine 500mg tablets true Inferred relationship Existential restriction modifier
EN-Lysine 500mg tablets (Ennogen Healthcare Ltd) Has active ingredient Lysine true Inferred relationship Existential restriction modifier
EN-Lysine 500mg tablets (Ennogen Healthcare Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
EN-Lysine 500mg tablets (Ennogen Healthcare Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
EN-Lysine 500mg tablets (Ennogen Healthcare Ltd) Has specific active ingredient L-lysine hydrochloride true Inferred relationship Existential restriction modifier
EN-Lysine 500mg tablets (Ennogen Healthcare Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
EN-Lysine 500mg tablets (Ennogen Healthcare Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Lysine true Inferred relationship Existential restriction modifier
EN-Lysine 500mg tablets (Ennogen Healthcare Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
EN-Lysine 500mg tablets (Ennogen Healthcare Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
EN-Lysine 500mg tablets (Ennogen Healthcare Ltd) Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
EN-Lysine 500mg tablets (Ennogen Healthcare Ltd) Has basis of strength substance Lysine true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
EN-Lysine 500mg tablets (Ennogen Healthcare Ltd) 30 tablet Has AMP True EN-Lysine 500mg tablets (Ennogen Healthcare Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start